Why is the Silex (ASX:SLX) share price sliding 8% today on positive news?

The Silex (ASX: SLX) share price has dropped more than 8% today despite the company gaining the green light for its GLE restructure.

| More on:
Downward red arrow with business man sliding down it signifying falling asx share price.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Silex Systems Ltd (ASX: SLX) share price is sliding lower today on news the United States government has approved the restructure of GE-Hitachi Global Laser Enrichment (GLE).

At the time of writing, the nuclear energy technology developer's shares are down 8.75% to $1.46.

The Silex share price has fallen today, despite the positive announcement. Could the share sell-down be due to investors already factoring in the outcome, which was first revealed on 8 January?

What's driving the Silex share price today?

In today's release, Silex advised it has formally received notice from the US Treasury Department Committee on Foreign Investment in the United States (CFIUS) to approve the transaction to restructure GLE.

The notice stated the CFIUS investigation found no national security concerns with the restructure. The latest approval now means that Silex has the go-ahead to proceed with its investment of GLE.

Silex will acquire a 51% stake, with uranium and nuclear fuel supplier Cameco to increase its interest from 24% to 49%.

As the deal draws close to being finalised, Silex, Cameco and GE-Hitachi Nuclear Energy (GEH) will shut down the membership interest purchase agreement (MIPA). Executed in December 2019, the joint agreement originally saw the purchase of GEH's 76% interest in GLE.

It is expected that the closure of MIPA will be concluded in the next few weeks.

Words from the CEO

Silex CEO and managing director Dr Michael Goldsworthy welcomed the news, saying:

The receipt of approval from CFIUS for the GLE transaction represents a significant milestone for Silex and reflects the dedicated efforts by the Silex team, our colleagues at Cameco and GEH, along with many representatives within the US Government, and we thank everyone for their contribution.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another red day on the markets this Wednesday.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Northern Star, Pro Medicus, and Web Travel shares

How does the team at Morgans rate these popular shares? Let's find out.

Read more »

Multiracial happy young people stacking hands outside - University students hugging in college campus - Youth community concept with guys and girls standing together supporting each other.
Share Gainers

Why 4DMedical and these ASX shares are up 200%+ in just a year

These shares have made their shareholders wealthy over the past year.

Read more »

Four people on the beach leap high into the air.
Opinions

4 reasons why I think BHP shares are a must-buy for 2026

The mining giant's shares are now 20% higher than this time last year.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A few gold nullets sit on an old-fashioned gold scale, representing ASX gold shares.
Broker Notes

Up 300% since August, why this surging ASX gold stock could keep racing higher

A leading broker forecasts more strong outperformance from this rocketing ASX gold stock.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Opinions

4DMedical shares crash 20% this week: Should investors cut their losses on the once-booming stock?

The shares are now down 6.61% for the year to date.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why 29Metals, Navigator Global, Praemium, and Xero shares are sinking today

These shares are having a tough time on hump day. But why?

Read more »